EVERESTOPharmaceuticals
Everest Organics Ltd — Profit & Loss Statement
₹203.45
+2.44%
Everest Organics Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 1.52 Cr | 0.00 | — |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.30 | 0.34 | — |
| Normalized EBITDA | 7.91 Cr | 11.87 Cr | 2.45 Cr | 8.15 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 5.05 Cr | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 5.05 Cr | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Reconciled Depreciation | 5.96 Cr | 5.80 Cr | 4.47 Cr | 3.80 Cr | — |
| Reconciled Cost Of Revenue | 98.54 Cr | 123.97 Cr | 154.12 Cr | 166.23 Cr | — |
| EBITDA | 7.91 Cr | 11.87 Cr | 7.50 Cr | 8.15 Cr | — |
| EBIT | 1.95 Cr | 6.08 Cr | 3.03 Cr | 4.36 Cr | — |
| Net Interest Income | -5.19 Cr | -5.47 Cr | -3.27 Cr | -3.05 Cr | — |
| Interest Expense | 5.19 Cr | 5.47 Cr | 2.94 Cr | 2.62 Cr | — |
| Normalized Income | -1.29 Cr | 0.14 Cr | -3.72 Cr | 1.14 Cr | — |
| Net Income From Continuing And Discontinued Operation | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Total Expenses | 158.22 Cr | 192.05 Cr | 185.73 Cr | 195.76 Cr | — |
| Diluted Average Shares | 0.97 Cr | 0.82 Cr | 0.79 Cr | 0.80 Cr | — |
| Basic Average Shares | 0.97 Cr | 0.82 Cr | 0.79 Cr | 0.80 Cr | — |
| Diluted EPS | -2.97 | 0.17 | -0.23 | 1.43 | — |
| Basic EPS | -2.97 | 0.17 | -0.23 | 1.43 | — |
| Diluted NI Availto Com Stockholders | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Net Income Common Stockholders | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Minority Interests | 0.00 | 0.00 | 0.00 | — | — |
| Net Income Including Noncontrolling Interests | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | -1.29 Cr | 0.14 Cr | -0.18 Cr | 1.14 Cr | — |
| Tax Provision | -1.95 Cr | 0.47 Cr | 0.27 Cr | 0.60 Cr | — |
| Pretax Income | -3.24 Cr | 0.61 Cr | 0.09 Cr | 1.74 Cr | — |
| Other Non Operating Income Expenses | 0.69 Cr | 0.89 Cr | 0.40 Cr | 14000.00 | — |
| Special Income Charges | 0.00 | 0.00 | 5.05 Cr | 0.00 | — |
| Net Non Operating Interest Income Expense | -5.19 Cr | -5.47 Cr | -3.27 Cr | -3.05 Cr | — |
| Interest Expense Non Operating | 5.19 Cr | 5.47 Cr | 2.94 Cr | 2.62 Cr | — |
| Operating Income | 1.26 Cr | 5.19 Cr | -2.68 Cr | 4.29 Cr | — |
| Operating Expense | 59.68 Cr | 68.08 Cr | 31.61 Cr | 29.53 Cr | — |
| Other Operating Expenses | 37.36 Cr | 43.31 Cr | 0.23 Cr | 0.44 Cr | — |
| Depreciation And Amortization In Income Statement | 5.96 Cr | 5.80 Cr | 4.47 Cr | 3.80 Cr | — |
| Depreciation Income Statement | 5.96 Cr | 5.80 Cr | 4.47 Cr | 3.80 Cr | — |
| Gross Profit | 60.94 Cr | 73.27 Cr | 28.93 Cr | 33.82 Cr | — |
| Cost Of Revenue | 98.54 Cr | 123.97 Cr | 154.12 Cr | 166.23 Cr | — |
| Total Revenue | 159.48 Cr | 197.24 Cr | 183.05 Cr | 200.05 Cr | — |
| Operating Revenue | 159.48 Cr | 197.24 Cr | 183.05 Cr | 200.05 Cr | — |
| Interest Income | — | 0.10 Cr | 0.03 Cr | 0.05 Cr | 0.11 Cr |
| Rent Expense Supplemental | — | 1.06 Cr | 0.56 Cr | 0.46 Cr | 0.32 Cr |
| Total Other Finance Cost | — | 0.62 Cr | 0.37 Cr | 0.49 Cr | 1.25 Cr |
| Interest Income Non Operating | — | 0.10 Cr | 0.03 Cr | 0.05 Cr | 0.11 Cr |
| Selling General And Administration | — | 11.14 Cr | 10.87 Cr | 10.06 Cr | 8.72 Cr |
| Selling And Marketing Expense | — | 7.21 Cr | 6.54 Cr | 5.45 Cr | 4.61 Cr |
| General And Administrative Expense | — | 3.93 Cr | 4.33 Cr | 4.61 Cr | 4.12 Cr |
| Rent And Landing Fees | — | 1.06 Cr | 0.56 Cr | 0.46 Cr | 0.32 Cr |
| Other Special Charges | — | — | -5.05 Cr | — | — |
| Impairment Of Capital Assets | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Everest Organics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.